Dr. Spyros Artavanis-Tsakonas is Professor Em. in the Department of Cell Biology at Harvard and Professeur honoraire au Collège de France. From 2012 to March 2017 he was the Chief Scientific Officer for Biogen. He joined the Department of Cell Biology at the Harvard Medical School in 1998 and was the founding Director of the Developmental and Regenerative Biology Program at Harvard. From 1999-2007 he was also the Isselbacher-Schwartz Professor, Massachusetts General Hospital Cancer Center. In 1998 he was elected Professor at the Collège de France, holding the Chair of Biology and Genetics of Development and taught there from until 2012.
He is the Founding Director of the Department of Genetics and Developmental Biology at Institut Curie, Paris, 2007-2009. Previously, he served as Professor at the Department of Biology and the Department of Cell Biology, at Yale University and as the Director of the Biological Sciences Division at Yale; he was a Howard Hughes Medical Institute Investigator from 1990 to 1998 when he left for Harvard. He has an M.A. in Chemistry from the ETH, Zurich and a Ph.D. in Molecular Biology from Cambridge University.
He did his postdoctoral research at Biozentrum, University of Basel, and the Biochemistry Department at Stanford University. In addition to his academic activities, Dr. Artavanis-Tsakonas is a co-founder of the Biotechnology companies Exelixis, Cellzome, and Anadys. He is the president and co-founder of the philanthropic organization Fondation Santé, which supports biomedical research and educational initiatives in Greece.